Document Detail


The changing role of the surgeon in the management of cancer in the university setting and its impact on resident training.
MedLine Citation:
PMID:  1434638     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A retrospective review was performed of 22,168 cancer cases registered by the Tumor Registry between 1965 and 1990. Eighty-six percent of these cases involved solid tumors; this number remained fairly constant throughout the study period. There was a significant trend toward more advanced disease at the time of presentation, most marked in the last 10 years; prior to 1980, 63.7% had localized or in situ cancer as opposed to only 49.4% since 1980 (P < 0.001). This suggested that more advanced cases were being submitted for treatment. As expected, more disseminated disease at the time of presentation was coupled with an overall decrease in the number of cases in which surgery comprised part of the treatment: 43.6% prior to 1980 vs. 38.1% after 1980. This trend has reversed, however, in the last 5 years. Though the number of cases in which surgery was the only treatment modality remained constant prior to and after 1985 (26.8% and 27.1%, respectively), the number of cases in which surgery was part of a multimodality treatment plan significantly increased (39.9% prior to 1985; 45.3% after 1985). This was coupled with a significant decrease in the number of cases treated with nonsurgical modalities alone (60.1% prior to 1985; 54.7% after 1985). Therefore, not only has the surgeon been called upon to operate on more advanced disease for cure in the last 5 years, but he or she has also become increasingly involved in multimodality treatment. Since 40.4% of university departments of surgery (as of 1990) did not provide specific training in surgical oncology, it is suggested that these departments reevaluate the objectives of their educational programs in view of the changing, increasingly complex role of the surgeon in the multidisciplinary approach to the care of the cancer patient.
Authors:
J Sariego; M Byrd; T Matsumoto; M Kerstein
Related Documents :
23140488 - Oncolytic reovirus type 3 (dearing) as a novel therapy in head and neck cancer.
9027318 - Circadian rhythms and autoregulatory transcription loops--going round in circles?
23242008 - Polyphenols as a chemopreventive agent in oral carcinogenesis: putative mechanisms of a...
23053498 - Elevation of serum c-reactive protein predicts failure of the initial antimicrobial tre...
22122468 - Base excision repair factors are promising prognostic and predictive markers in cancer.
25102298 - Role of microrna-34 family in cancer with particular reference to cancer angiogenesis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of surgical oncology     Volume:  51     ISSN:  0022-4790     ISO Abbreviation:  J Surg Oncol     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1992-12-11     Completed Date:  1992-12-11     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0222643     Medline TA:  J Surg Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  143-5; discussion 145-6     Citation Subset:  IM    
Affiliation:
Department of Surgery, Hahnemann University, Philadelphia, PA 19102.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Curriculum
General Surgery / trends*
Hospitals, University*
Humans
Internship and Residency*
Neoplasms / therapy*
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The characterization of inconsistencies in self-reports of alcohol and marijuana use in a longitudin...
Next Document:  Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor recep...